An Australian subsidiary of Syncor has acquired Radpharm Scientific, distributor and manufacturer of diagnostic radiopharmaceuticals. Based in Canberra, Radpharm distributes its products to more than 160 nuclear medicine practices in Australia and
An Australian subsidiary of Syncor has acquired Radpharm Scientific, distributor and manufacturer of diagnostic radiopharmaceuticals. Based in Canberra, Radpharm distributes its products to more than 160 nuclear medicine practices in Australia and exports to New Zealand, Singapore, Malaysia, Thailand, and Hong Kong. The acquisition gives Syncor a presence in Canberra along with its existing sites in Sydney, Perth, and Brisbane.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.